BioAmber Closes Series B Funding Round

20:19 PM | May 5, 2011 | Vincent Valk

BioAmber (Minneapolis), a maker of biobased succinic and adipic acid, has completed a Series B funding round, raising $45 million. Naxos Capital Partners (Luxembourg), a venture capital firm, led the...